Antibiotic Answers
A Review of Mycobacterium avium Complex Disease Treatment in Children Living With HIV/AIDS
The nontuberculous mycobacteria comprise more than 190 species and subspecies of bacteria that can cause disease in people of all ages.
JULY 3, 2025
Pediatric Antimicrobial Stewardship: Smart Choices for Tiny Warriors
Antimicrobial resistance is a growing health crisis, contributing significantly to morbidity and mortality in adults and children.
APRIL 29, 2025
Looking at 2 Antimicrobials for Drug-Resistant Pseudomonas aeruginosa
The purpose of this review is to discuss the in vitro activity and real-world evidence of ceftolozane-tazobactam and ceftazidime-avibactam against P. aeruginosa.
FEBRUARY 26, 2025
Outpatient Antimicrobial Stewardship: A Road Less Traveled
Antimicrobial resistance is an international public health threat and a leading cause of mortality.
DECEMBER 30, 2024
Antimicrobial Duos for Infective Endocarditis Caused by Enterococcus Species
Infective endocarditis, a serious infection involving the endocardium and heart valves, is associated with a high degree of illness and mortality, and has an annual incidence that has continued to increase throughout the United States.
OCTOBER 21, 2024
Carbapenem-Resistant Enterobacterales (CRE): A Focus on Ceftazidime-Avibactam and Meropenem-Vaborbactam
Antimicrobial resistance has emerged as a leading global health threat with mortality rates due to infections from resistant organisms rising each year.
AUGUST 28, 2024
Bacterial Infections and Antibiotic Use In People Living With HIV/AIDS
In the summer of 1981, the CDC released a Morbidity and Mortality Weekly Report that described Pneumocystis carinii pneumonia, a rare condition, in five previously healthy young males in Los Angeles.
JUNE 17, 2024
Evaluation of Omadacycline for Mycobacterium abscessus: Focus on In Vitro Activity and Clinical Outcomes
Infections caused by M. abscessus are challenging clinically and difficult to treat because M. abscessus is intrinsically resistant to most antibiotics currently available, including the classic anti-tuberculous agents.
APRIL 15, 2024
Resistant Gram-Negative Bacteria: Focus on the Real-World Use of Novel Beta-Lactams in Children
Antimicrobial resistance in gram-negative bacteria is associated with a significant risk for morbidity and mortality.
MARCH 1, 2024
Long-Acting Lipoglycopeptides: Agents With Potential in Serious Gram-Positive Infections Requiring Long-Term Therapy
Gram-positive organisms, including drug-resistant strains, are responsible for several life-threatening infections.
OCTOBER 20, 2023
Right Drug for the HABP and VABP Patient
Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia are among the most common and serious infections occurring in hospitalized patients.
AUGUST 23, 2023
Managing Hard-to-Treat Infections: Parenteral or Oral Antibiotics?
The inspiration for this article comes from our colleague Dr. Brad Spellberg, who firmly believes in appropriate antibiotic prescribing, which goes beyond drug choice alone to also consider both formulation and duration of therapy.
APRIL 5, 2023
